Search
Patexia Research
Case number 3:18-cv-11265

AMGEN INC. v. ALKEM LABORATORIES LTD. > Summary

Court Case Number 3:18-cv-11265

Filing Date Jun 29, 2018

Termination Date May 19, 2021

Court New Jersey District Court

Status Dismissed - Settled

JudgesMichael A. Shipp, Douglas E. Arpert

Plaintiff

2

Celgene

Amgen

Defendant

Alkem Laboratories Ltd.

Cause

15:1126 Patent Infringement

Related Patents

Doc No Title Issue date
10092541 Methods for the treatment of diseases ameliorated by PDE4 inhibition using dosage titration of apremilast Oct 9, 2018
09724330 Methods of using (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione Aug 8, 2017
09018243 Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereof Apr 28, 2015
08455536 Methods of using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline 1,3-dione Jun 4, 2013
07893101 Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereof Feb 22, 2011
07659302 Methods of using (+)-2-[1-(3-ethoxy-4 methoxyphenyl)-2-methylsulfonylethyl]-4 acetylaminoisoindoline 1,3-dione Feb 9, 2010
07427638 (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione:, and methods of synthesis and compositions thereof Sep 23, 2008
06962940 (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof Nov 8, 2005
Menu